Jan 31, 2014

BRIC-a-BRAC: January 31, 2014

1. An interesting article in discusses Russia's focus on developing a "world class" biopharmaceutical sector. The article states that IMS Health predicts that Russia's $16.6 billion in annual prescription drug sales (11th in market size) will rise to $26.6 billion by 2017 (8th in market size). Specifically, the article discusses ChemRar, a consortia of biotech startups […]
back to top